Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma

Publisher： Karger

E-ISSN： 1423-0399|75|3|252-257

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.75, Iss.3, 2005-10, pp. : 252-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 5, 2015-05 ,pp. : 458-464

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of Vascular Endothelial Growth Factor, Receptor KDR and p53 Protein in Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 81, Iss. 1, 2008-07 ,pp. : 72-76

Karger

Access to resources Recommend Favorite

Expression of p57/Kip2 Protein in Hepatocellular Carcinoma

By  

Oncology, Vol. 61, Iss. 3, 2001-09 ,pp. : 221-225

Karger

Access to resources Recommend Favorite

Exon 2 Methylation Inhibits hepaCAM Expression in Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 85, Iss. 3, 2010-07 ,pp. : 347-354

Karger

Access to resources Recommend Favorite

Relation between Cyclooxygenase-2 Expression and Clinicopathologic Parameters with Patient Prognosis in Transitional Cell Carcinoma of the Bladder

By  

Urologia Internationalis, Vol. 76, Iss. 1, 2006-01 ,pp. : 51-56

Karger

Access to resources Recommend Favorite